Literature DB >> 12778777

Quality of life in nonorganic and organic sleep disorders: I. Comparison with normative data.

Bernd Saletu1, Wolfgang Prause, Henriette Löffler-Stastka, Peter Anderer, Nadja Brandstätter, Ali Zoghlami, Gerda Saletu-Zyhlarz, Heinz Katschnig.   

Abstract

Subjective health-related quality of life (HRQoL) was investigated in 100 patients with disturbed sleep (39 women aged 52 +/- 13 years and 61 men aged 53 +/- 10 years) referred to the sleep laboratory and compared with HRQoL in 100 normal healthy adults. Measurements included the Quality of Life Index (QLI) (Mezzich and Cohen), and objective (polysomnographic) and subjective (psychometric) quality of sleep and awakening. Statistical analysis (Mann-Whitney U-test) showed HRQoL to be significantly reduced in sleep disorders (SDs), with a more pronounced reduction in nonorganic than in organic SDs. Patients with nonorganic hypersomnia were more disturbed than those with nonorganic insomnia. Within organic SDs, patients with apnea were more disturbed than those with obstructive snoring. Out of ten elementary HRQoL components, seven were disturbed in SDs: physical well-being, psychological well-being, self-care and independent functioning, occupational functioning, interpersonal functioning, personal fulfillment, and overall quality of life. No differences between patients and normal healthy subjects where found in the components social support, community and services support or spiritual fulfillment. Patients suffering from nonorganic SDs had significantly worse scores in physical and psychological well-being and overall quality of life than those with organic SDs. Patients with both SDs and additional diagnoses of affective disorders had more profoundly reduced HRQoL than those with anxiety disorders. Follow-up of 51 patients (31 with nonorganic SDs and 20 with organic SDs) one year after sleep laboratory investigation and subsequent treatment found significantly improved HRQoL compared with pre-treatment. Moreover, patients diagnosed and treated in the sleep laboratory showed lower re-hospitalization rats.

Entities:  

Mesh:

Year:  2003        PMID: 12778777     DOI: 10.1007/bf03040323

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   1.704


  31 in total

1.  Quality of life in people with insomnia.

Authors:  G K Zammit; J Weiner; N Damato; G P Sillup; C A McMillan
Journal:  Sleep       Date:  1999-05-01       Impact factor: 5.849

2.  Proposed supplements and amendments to 'A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects', the Rechtschaffen & Kales (1968) standard.

Authors:  T Hori; Y Sugita; E Koga; S Shirakawa; K Inoue; S Uchida; H Kuwahara; M Kousaka; T Kobayashi; Y Tsuji; M Terashima; K Fukuda; N Fukuda
Journal:  Psychiatry Clin Neurosci       Date:  2001-06       Impact factor: 5.188

3.  The Spanish version of the quality of life index: presentation and validation.

Authors:  J E Mezzich; M A Ruipérez; C Pérez; G Yoon; J Liu; S Mahmud
Journal:  J Nerv Ment Dis       Date:  2000-05       Impact factor: 2.254

4.  Relationships between alexithymia, emotional control, and quality of life in patients with inflammatory bowel disease.

Authors:  R Verissimo; R Mota-Cardoso; G Taylor
Journal:  Psychother Psychosom       Date:  1998       Impact factor: 17.659

5.  Measurement of general health status in obstructive sleep apnea hypopnea patients.

Authors:  C Fornas; E Ballester; E Arteta; C Ricou; A Diaz; A Fernandez; J Alonso; J M Montserrat
Journal:  Sleep       Date:  1995-12       Impact factor: 5.849

6.  Clinical economics and sleep disorders.

Authors:  B Crawford
Journal:  Sleep       Date:  1997-10       Impact factor: 5.849

7.  Automobile accidents in patients with sleep disorders.

Authors:  M S Aldrich
Journal:  Sleep       Date:  1989-12       Impact factor: 5.849

8.  Factors impairing daytime performance in patients with sleep apnea/hypopnea syndrome.

Authors:  K Cheshire; H Engleman; I Deary; C Shapiro; N J Douglas
Journal:  Arch Intern Med       Date:  1992-03

Review 9.  EEG topography and tomography in diagnosis and treatment of mental disorders: evidence for a key-lock principle.

Authors:  B Saletu; P Anderer; G M Saletu-Zyhlarz; R D Pascual-Marqui
Journal:  Methods Find Exp Clin Pharmacol       Date:  2002

10.  Effects of zopiclone on quality of life in insomnia.

Authors:  I Hindmarch
Journal:  Eur Psychiatry       Date:  1995       Impact factor: 5.361

View more
  6 in total

1.  Controlled clinical, polysomnographic and psychometric studies on differences between sleep bruxers and controls and acute effects of clonazepam as compared with placebo.

Authors:  Alexander Saletu; Silvia Parapatics; Peter Anderer; Michael Matejka; Bernd Saletu
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2009-07-15       Impact factor: 5.270

2.  [Benefits of an add-on treatment with the synthetic cannabinomimetic nabilone on patients with chronic pain--a randomized controlled trial].

Authors:  Martin Pinsger; Wolfgang Schimetta; Dieter Volc; Erich Hiermann; Franz Riederer; Werner Pölz
Journal:  Wien Klin Wochenschr       Date:  2006-06       Impact factor: 1.704

3.  [Diagnosis and therapy of restless legs syndrome in the doctor's office].

Authors:  Michael Saletu; Martina Esberger-Chowdhury; Josef Zeitlhofer; Lüder Deecke
Journal:  Wien Klin Wochenschr       Date:  2004-08-31       Impact factor: 1.704

4.  Quality of life in nonorganic and organic sleep disorders: II. Correlation with objective and subjective quality of sleep and awakening.

Authors:  Wolfgang Prause; Bernd Saletu; Peter Anderer; Georg Gruber; Henriette Löffler-Stastka; Gerhard Klösch; Magdalena Mandl; Elisabeth Grätzhofer; Gerda Saletu-Zyhlarz; Heinz Katschnig
Journal:  Wien Klin Wochenschr       Date:  2003-05-30       Impact factor: 1.704

5.  Functional status in the elderly with insomnia.

Authors:  Jesús López-Torres Hidalgo; Clotilde Boix Gras; Yolanda David García; Juan Téllez Lapeira; José María del Campo del Campo; María Angeles López Verdejo
Journal:  Qual Life Res       Date:  2006-10-11       Impact factor: 3.440

6.  The societal costs of insomnia.

Authors:  Alan G Wade
Journal:  Neuropsychiatr Dis Treat       Date:  2010-12-20       Impact factor: 2.570

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.